SARS-CoV-2 Nucleocapsid anticorps (HRP)
Aperçu rapide pour SARS-CoV-2 Nucleocapsid anticorps (HRP) (ABIN7091994)
Antigène
Voir toutes SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human Histone H1.2
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:300-5000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
-
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
Autre désignation
- SARS-CoV-2 N
-
Sujet
- Optional[synonyms]: SARS-CoV-2 Nucleocapsid Protein, SARS-CoV-2 NP, nucleocapsid protein [Severe acute respiratory syndrome coronavirus 2], novel coronavirus N Protein, novel coronavirus Nucleocapsid Protein, 2019-nCoV Nucleoprotein, 2019-nCoV N, 2019nCoV N, 2019-nCoV N Protein, 2019 ncov N Protein, 2019-nCoV nucleocapsid protein.
Antigène
-